Ruboxistaurin
Authors:
- 1 January 2006
- journal article
- research article
- Published by Portico in Drugs of Today
- Vol. 42 (9) , 577-585
Abstract
Ruboxistaurin is a potent and specific inhibitor of the beta isoform of protein kinase C. Overactivation of protein kinase C has been demonstrated in patients with type 2 diabetes, and is postulated to play a major role in the pathogenesis of diabetic microvascular complications, which include diabetic retinopathy, neuropathy and nephropathy. The role of protein kinase C in promoting tissue injury in patients with diabetes, and the pharmacologic and clinical studies illustrating the potential of ruboxistaurin to reduce the burden of diabetic microvascular complications will be discussed in this article (c) 2006 Prous Science. All rights reserved.Keywords
This publication has 23 references indexed in Scilit:
- IN VIVO METABOLISM OF [14C]RUBOXISTAURIN IN DOGS, MICE, AND RATS FOLLOWING ORAL ADMINISTRATION AND THE STRUCTURE DETERMINATION OF ITS METABOLITES BY LIQUID CHROMATOGRAPHY/MASS SPECTROMETRY AND NMR SPECTROSCOPYDrug Metabolism and Disposition, 2006
- Inhibition of PKC by Oral Administration of Ruboxistaurin Is Well Tolerated and Ameliorates Diabetes-Induced Retinal Hemodynamic Abnormalities in PatientsInvestigative Ophthalmology & Visual Science, 2006
- Sural sensory action potential identifies diabetic peripheral neuropathy responders to therapyMuscle & Nerve, 2005
- Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C β-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trialClinical Therapeutics, 2005
- Renal damage in patients with Type 2 diabetes: a strong predictor of mortalityDiabetic Medicine, 2005
- Disposition of LY333531, a selective protein kinase Cβinhibitor, in the Fischer 344 rat and beagle dogXenobiotica, 2002
- Biochemistry and molecular cell biology of diabetic complicationsNature, 2001
- Alpha-lipoic acid: effect on glucose uptake, sorbitol pathway, and energy metabolism in experimental diabetic neuropathy.Diabetes, 1999
- Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideasDiabetologia, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998